Megan Elizabeth Bowles Clowse, MD, MPH, is an associate professor of medicine in the Division of Rheumatology and Immunology at Duke University School of Medicine. She is a clinical associate director of Duke Forge, where health data is put into action. Her clinical research focuses on the management of rheumatologic diseases in pregnancy. She is the director of the Vasculitis-Pregnancy Registry. Additionally, she has collected prospective pregnancies in women with rheumatic disease in the Duke Autoimmunity in Pregnancy Registry, which includes clinical data, pregnancy outcomes and a large sample repository. She received her MD from Vanderbilt University and her MPH at the University of California, Los Angeles.
You Might Also Like
Explore This IssueDecember 2018
David Leverenz, MD, is pursuing a fellowship in rheumatology and immunology at Duke University School of Medicine.
Dr. Clowse has received funding from the following sources:
- Consulting: UCB, Regeneron, AstraZeneca, BMS
- Investigator-initiated grants: Janssen, Pfizer
- Independent Medical Education grant: GlaxoSmithKline
Dr. Leverenz has nothing of relevance to disclose.
- Collip JB, Anderson EM, Thomson DL. The adrenotropic hormone of the anterior pituitary lobe. Lancet. 1933 Aug 12;222(5737):347–348.
- Glyn JH. The discovery of cortisone: A personal memory. BMJ. 1998 Sep 19;317(7161):822.
- Pollack A. Questcor finds profits, at $28,000 a vial. The New York Times. 2012 Dec 29.
- Hartung DM, Johnston K, Cohen DM, et al. Industry payments to physician specialists who prescribe repository corticotropin. JAMA Network Open. 2018 Jun 29;1(2):e180482.
Editor’s note: Reprinted from Duke Forge by permission.